Home › Edwards Lifesciences Receives Approval for SAPIEN XT in Japan
 

Keywords :   


Edwards Lifesciences Receives Approval for SAPIEN XT in Japan

2013-06-24 06:00:00| Industrial Newsroom - All News for Today

IRVINE, CA &ndash; Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved the Edwards SAPIEN XT valve, making it the country's first commercially available transcatheter aortic heart valve.<br /> <br /> The company expects to obtain reimbursement approval from MHLW by year's end, and will initiate a full launch in Japan immediately ...This story is related to the following:Medical Valves |

Tags: japan approval receives edwards

Category:Industrial Goods and Services

Latest from this category

All news
17.06New Federal Government Filing Requirement Regarding Ownership of LLCs and Corporations
17.06Manufacturers Reps That Sell to International Customers June 26 Networking Event
17.06Avoid $591 Daily Penalty From the U.S. Treasury Department
15.06With Gratitude for a Job Well Done
Industrial Goods and Services »
18.06Farm Progress America, June 18, 2024
18.06Farm Progress America, June 18, 2024
18.06Potential Tropical Cyclone One Graphics
18.06Potential Tropical Cyclone One Forecast Discussion Number 3
18.06Potential Tropical Cyclone One Wind Speed Probabilities Number 3
18.06Potential Tropical Cyclone One Public Advisory Number 3
18.06Summary for Potential Tropical Cyclone One (AT1/AL012024)
18.06Potential Tropical Cyclone One Forecast Advisory Number 3
More »